Your browser doesn't support javascript.
loading
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.
Cozzi-Lepri, A; Zangerle, R; Machala, L; Zilmer, K; Ristola, M; Pradier, C; Kirk, O; Sambatakou, H; Fätkenheuer, G; Yust, I; Schmid, P; Gottfredsson, M; Khromova, I; Jilich, D; Flisiak, R; Smidt, J; Rozentale, B; Radoi, R; Losso, M H; Lundgren, J D; Mocroft, A.
  • Cozzi-Lepri A; Centre for Clinical Research, Modelling and Epidemiology, Research Department of Infection and Population Health, Institute for Global Health, University College London Medical School, Royal Free Campus, London, UK.
  • Zangerle R; Medical University Innsbruck, Innsbruck, Austria.
  • Machala L; Department of Infectious and Tropical Diseases, Third Faculty of Medicine, Charles University and Na Bulovce Hospital, Prague, Czech Republic.
  • Zilmer K; West-Tallinn Central Hospital, Tallinn, Estonia.
  • Ristola M; Helsinki University Hospital, Helsinki, Finland.
  • Pradier C; L'Archet 1 Hospital, University of Nice Sophia-Antipolis, Nice, France.
  • Kirk O; Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Sambatakou H; Ippokration General Hospital, Athens, Greece.
  • Fätkenheuer G; Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany.
  • Yust I; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
  • Schmid P; Ichilov Hospital, Tel Aviv-Yafo, Israel.
  • Gottfredsson M; Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Khromova I; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland and Landspitali University Hospital, Reykjavík, Iceland.
  • Jilich D; Centre for HIV/AIDS and infectious diseases, Kaliningrad, Russian Federation.
  • Flisiak R; Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University and Na Bulovce Hospital, Prague, Czech Republic.
  • Smidt J; Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland.
  • Rozentale B; Ida-Viru Central Hospital, Kohtla-Jarve.
  • Radoi R; Infectology Center of Latvia, Riga, Latvia.
  • Losso MH; Dr. Victor Babes Hospital, Bucuresti, Romania.
  • Lundgren JD; Hospital J.M. Ramos Mejia, Buenos Aires, Argentina.
  • Mocroft A; Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
HIV Med ; 19(2): 102-117, 2018 02.
Article en En | MEDLINE | ID: mdl-28984429
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Terapia Antirretroviral Altamente Activa / Antirretrovirales / Raltegravir Potásico / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Terapia Antirretroviral Altamente Activa / Antirretrovirales / Raltegravir Potásico / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article